Dublin, Dec. 06, 2023 (GLOBE NEWSWIRE) -- The "Israel: CBD and Cannabis Regulation" report has been added to ResearchAndMarkets.com's offering.
The constant government changes that have taken place over the last three years, along with the general composition of the Knesset (Israel's parliament) with multiple parties with different ideologies, makes predicting the future of Israel's CBD sector difficult. CBD is no longer considered a scheduled substance and will be allowed in foods and cosmetics once approved by the Ministry of Health.
A new reform in medical cannabis is expected to enter into force in March 2024, which will ease the regulatory burden for patients and industry members.
This report provides a detailed overview of Israel's regulatory framework for CBD, hemp and cannabis.
Key Topics Covered:
- Executive summary
- Outlook
- Hemp plant
- Extracts and synthetics
- Finished products containing CBD and extracts
- Import and export requirements
- Minor cannabinoids
- Medical cannabis
- Recreational cannabis
- Relevant laws
- Relevant bodies
For more information about this report visit https://www.researchandmarkets.com/r/a0jgkc
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
